Действие трифторперазина на гемолиз эритроцитов в гипертонических растворах электролитов

Manifestation of antihemolytic activity of trifluoperazine (TFP) during hypertonic hemolysis of erythrocytes depends on temperature and state of cells. Both the reduction of temperature down to 0°C and preliminary incubation of cells in presence of 0.7 M NaCl result in decrease of antihemolytic act...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2002
Автори: Shpakova, N. M., Dunaevskaya, O. N., Synchikova, O. P., Bondarenko, V. A.
Формат: Стаття
Мова:English
Опубліковано: Publishing House ‘Akademperiodyka’ of the National Academy of Sciences of Ukraine; Institute for Problems of Cryobiology and Cryomedicine 2002
Онлайн доступ:https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/952
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Problems of Cryobiology and Cryomedicine

Репозитарії

Problems of Cryobiology and Cryomedicine
Опис
Резюме:Manifestation of antihemolytic activity of trifluoperazine (TFP) during hypertonic hemolysis of erythrocytes depends on temperature and state of cells. Both the reduction of temperature down to 0°C and preliminary incubation of cells in presence of 0.7 M NaCl result in decrease of antihemolytic activity of trifluoperazine at the removal of cells into 4.0 M NaCl. Combined action of low temperature and preliminary dehydration are accompanied by inversion of the effect of the amphiphile and supplementary lysis of cells in 4.0 M NaCl. Cell treatment by neuraminidase and proteolytic enzymes does not affect the manifestation of antihemolytic activity of trifluoperazine during hypertonic hemolysis of erythrocytes at 37°C, the preliminary dehydration of such kind of cells results in its decrease. Modification of membrane glycoproteins as a result of treatment by proteolytic enzymes is accompanied by increase in antihemolytic activity of trifluoperazine at 0°C. The results obtained are discussed from the point of view of processes underlying the formation and stabilization of transmembrane defects.Â